Prevalence and Risk Factors of Cytopenia in HIV-Infected Patients before and after the Initiation of HAART
Table 1
The demographic and clinical characteristics of participants.
Characteristics
Total (n = 4325)
Noncytopenia (n = 3501)
Cytopenia (n = 824)
Age (years)
<40
2796 (64.6%)
2442 (67.6%)
354 (49.8%)
≥40
1530 (35.4%)
1173 (32.4%)
357 (50.2%)
Sex
Male
4048 (93.6%)
3340 (95.4%)
708 (85.9%)
Female
277 (6.4%)
161 (4.6%)
116 (14.1%)
WHO stage
I
3307 (76.5%)
2795 (79.8%)
512 (62.1%)
II
234 (5.4%)
188 (5.4%)
46 (5.6%)
III
281 (6.5%)
217 (6.2%)
64 (7.8%)
IV
503 (11.6%)
301 (8.6%)
202 (24.5%)
BMI (kg/m2)
<18.5
337 (9.8%)
240 (8.1%)
97 (19.7%)
18.5–24
2248 (65.3%)
1938 (65.7%)
310 (62.9%)
>24
858 (24.9%)
772 (26.2%)
86 (17.4%)
CD4+ T-cell counts (/μl)
<200
1475 (35.6%)
949 (22.9%)
526 (66.2%)
≥200
2667 (64.4%)
2398 (71.6%)
269 (33.8%)
Viral load (copies/ml)
≥100000
979 (30%)
699 (26.2%)
280 (48%)
<100000
2280 (70%)
1977 (73.9%)
303 (52%)
Infection routes
Sexual
3933 (91%)
3258 (93.1%)
675 (81.9%)
Others
392 (9.9%)
243 (6.9%)
149 (18.1%)
HCV-coinfection
No
3481 (80.5%)
2934 (81.2%)
547 (76.9%)
Yes
77 (19.5%)
681 (15.7%)
164 (23.1%)
HBV-coinfection
No
4111 (95%)
3474 (96.1%)
637 (89.6%)
Yes
215 (5%)
141 (3.9%)
74 (10.4%)
Note: data are presented as n (%); WHO, World Health Organization; BMI, body mass index; variable had missing values: BMI = 883; HIV RNA = 1066; CD4+ T-cell counts = 183.